Bleeding Risk Following Systemic Fluconazole or Topical Azoles in Patients with Atrial Fibrillation on Apixaban, Rivaroxaban, or Dabigatran-Reference-Cited by-同舟云学术

Bleeding Risk Following Systemic Fluconazole or Topical Azoles in Patients with Atrial Fibrillation on Apixaban, Rivaroxaban, or Dabigatran

Published:2021-11 Issue: Volume: Page:
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Holt Anders^ORCID,Strange Jarl E.,Rasmussen Peter Vibe,Blanche Paul,Nouhravesh Nina,Jensen Mads Hashiba^ORCID,Schjerning Anne-Marie,Schou Morten,Torp-Pedersen Christian,Gislason Gunnar H.^ORCID,Hansen Morten Lock,McGettigan Patricia,Lamberts Morten

Funder

Helsefonden

Dagmar Marshalls Fond

Snedkermester Sophus Jacobsen Og Hustru Astrid Jacobsens Fond

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation;Steffel;Eur Heart J,2018

2. European Medicines Agency. European public assessment report, Eliquis. Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/eliquis. Accessed June 22, 2021.

3. European Medicines Agency. European public assessment report, Pradaxa. Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/pradaxa. Accessed June 22, 2021.

4. European Medicines Agency. European public assessment report, Xarelto. Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/xarelto. Accessed June 22, 2021.

5. European Medicines Agency. European public assessment report, Lixiana. Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/lixiana. Accessed June 23, 2021.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and Safety of Different Oral Anticoagulants with P-glycoprotein/ CYP3A4 Inhibitors: A Network Meta-analysis;Current Pharmaceutical Design;2024-04

2. Pharmacological options for Candida albicans Endocarditis at the roadblock with irrecoverable prosthetics and drug interactions: a case report and review of literature;BMC Infectious Diseases;2023-05-08

3. Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus;Journal of the American College of Cardiology;2023-04

4. Managing the Drug-Drug Interaction With Apixaban and Primidone: A Case Report;Hospital Pharmacy;2023-01-27

5. Impact of concomitant fluconazole on direct oral anticoagulant bleeding risk;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-11-04